Reply to Letter to the Editor: Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
作者信息
Miller Paul D, Yu Zhigang
机构信息
Colorado Center for Bone Health, Lakewood, CO, USA.
Amgen Inc., Thousand Oaks, CA, USA.
出版信息
J Bone Miner Res. 2023 Feb;38(2):356. doi: 10.1002/jbmr.4761. Epub 2023 Jan 25.
PMID:36698050
Abstract
摘要
Zotero 插件